Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-08 Sale |
2023-11-13 7:29 pm |
Panbela Therapeutics Inc. | PBLA | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner |
72,874 | $0.71 | $51,741 | 397,954 (Indirect) |
View |
| 2023-01-30 Purchase |
2023-02-01 4:37 pm |
Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO |
4,444 | $0 | $0 | 16,756 (Direct) |
View |
| 2023-01-30 Purchase |
2023-02-01 4:36 pm |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
4,444 | $0 | $0 | 26,768 (Direct) |
View |
| 2022-10-04 Purchase |
2022-10-06 6:14 pm |
Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Director 10% Owner |
165,000 | $0 | $0 | 833,387 (Indirect Direct) |
View |
| 2022-10-04 Purchase |
2022-10-06 5:26 pm |
Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner |
200,000 | $0 | $0 | 879,273 (Indirect Direct) |
View |
| 2022-10-04 Purchase |
2022-10-06 5:24 pm |
Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director |
33,000 | $0 | $0 | 416,576 (Indirect Direct) |
View |
| 2020-09-10 Purchase |
2020-09-14 5:52 pm |
Sun BioPharma Inc. | SNBP | Simpson Jennifer K. President and CEO |
1,000 | $2.7371 | $2,737 | 3,424 (Direct) |
View |
| 2020-09-04 Purchase |
2020-09-09 9:28 pm |
Sun BioPharma Inc. | SNBP | Schaffer Paul W. Director |
25,000 | $2.5093 | $62,732 | 190,085 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-10-29 7:38 pm |
2024-10-22 2025-04-22 |
Panbela Therapeutics Inc. | PBLA | Nant Capital LLC SOON-SHIONG PATRICK 10% Owner |
0 | $0 | 7,702,702 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 4:26 pm |
N/A 2034-10-01 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
25,480 | $0 | 25,480 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 4:25 pm |
N/A 2034-10-01 |
Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO |
72,800 | $0 | 72,800 (Direct) |
View |
Ownership |
2023-11-13 7:27 pm |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner |
0 | $0 | 360,464 (Indirect) |
View |
| 2023-09-12 Gift |
2023-09-14 4:06 pm |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director |
275 | $0 | 27 (Indirect) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:26 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO |
99,383 | $0 | 99,383 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:25 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
34,369 | $0 | 34,369 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:24 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Director 10% Owner |
8,333 | $0 | 8,333 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:22 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Donovan Daniel Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:22 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Fratamico Arthur Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:21 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:19 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | MATHIESEN JEFFREY S Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:18 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner |
8,333 | $0 | 8,333 (Direct) |
View |
Ownership |
2022-06-27 08:44 am |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | Jacob Jeffrey E. Director |
0 | $0 | 685,797 (Direct) |
View |
Ownership |
2022-06-24 4:46 pm |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | Donovan Daniel Director |
0 | $0 | 375,036 (Direct) |
View |
| 2021-09-13 Option Award |
2021-09-15 6:00 pm |
N/A 2031-09-13 |
Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO |
19,125 | $0 | 19,125 (Direct) |
View |
| 2021-09-13 Option Award |
2021-09-15 5:59 pm |
N/A 2031-09-13 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
12,135 | $0 | 12,135 (Direct) |
View |
| 2021-01-06 Gift |
2021-06-11 10:34 am |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | Gagnon Suzanne Director |
11,426 | $0 | 46,284 (Indirect) |
View |
| 2021-05-25 Option Award |
2021-05-27 8:54 pm |
N/A 2031-05-25 |
Panbela Therapeutics Inc. | PBLA | Fratamico Arthur Director |
16,684 | $0 | 21,983 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 8:52 pm |
N/A 2031-05-25 |
Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner |
16,684 | $0 | 391,641 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 8:51 pm |
N/A 2031-05-25 |
Panbela Therapeutics Inc. | PBLA | MATHIESEN JEFFREY S Director |
16,684 | $0 | 22,559 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 8:49 pm |
N/A 2031-05-25 |
Panbela Therapeutics Inc. | PBLA | Schaffer Paul W. Director |
16,684 | $0 | 209,704 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 8:48 pm |
N/A 2031-05-25 |
Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Director 10% Owner |
16,684 | $0 | 433,755 (Direct) |
View |
| 2021-03-30 Option Award |
2021-04-01 09:33 am |
N/A 2031-03-30 |
Panbela Therapeutics Inc. | PBLA | Simpson Jennifer K. President and CEO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2021-03-30 Option Award |
2021-04-01 09:33 am |
N/A 2031-03-30 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-30 Option Award |
2021-04-01 09:31 am |
N/A 2031-03-30 |
Panbela Therapeutics Inc. | PBLA | Gagnon Suzanne Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-03-30 Option Award |
2021-04-01 09:31 am |
N/A 2031-03-30 |
Panbela Therapeutics Inc. | PBLA | Cullen Michael T. Executive Chairman 10% Owner |
55,000 | $0 | 55,000 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-03 4:15 pm |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | Schaffer Paul W. Director |
2,875 | $0 | 192,960 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-03 4:13 pm |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | MATHIESEN JEFFREY S Director |
2,875 | $0 | 5,875 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-03 4:12 pm |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | Schemel Donald Robert Director 10% Owner |
2,875 | $0 | 374,957 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-03 4:11 pm |
N/A N/A |
Panbela Therapeutics Inc. | PBLA | Fratamico Arthur Director |
2,875 | $0 | 5,299 (Direct) |
View |